How AI is shortening drug discovery timelines in China
Insilico Medicine has lowered the time wanted to supply some drug growth candidates to about one yr by combining synthetic intelligence with laboratory analysis in China, in line with CEO Alex Zhavoronkov. The Hong Kong-listed firm’s quickest programme reached candidate nomination in 9 months, whereas its typical timeline is about 13 months, Zhavoronkov mentioned. He…
